Skip to content

The Fluid Translation of Research Into Practice Study

The Fluid Translation of Research Into Practice Study (Fluid-TRIPS): An International Cross-Sectional Survey of Fluid Resuscitation Practice

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02002013
Acronym
Fluid-TRIPS
Enrollment
2000
Registered
2013-12-05
Start date
2014-04-30
Completion date
2014-12-31
Last updated
2015-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Care, Fluid Resuscitation

Keywords

Adult, ICU patient, Fluid resuscitation, observational study

Brief summary

Translating reliable evidence on fluid resuscitation of intensive care patients into clinical practice - Improving patient outcomes and containing public health costs

Detailed description

The Fluid-Translation of Research into Practice Study (TRIPS) is an international, single day, cross-sectional study planned for the second quarter of 2014, coordinated by the George Institute for Global Health, with the purpose of documenting prescribing practices for fluid resuscitation in intensive care units (ICUs) worldwide. This international cross-sectional study follows on from the publication of large-scale randomized controlled trials and meta-analyses of fluid resuscitation, which provide evidence of how fluid resuscitation may affect patient-centered outcomes. Fluid-TRIPS is a repeat of the Saline versus Albumin for Fluid Evaluation (SAFE)-TRIPS which was an international cross-sectional survey conducted in 2007 that had 391 ICU's participate from 25 countries and provided insight into international fluid resuscitation practice at that time. Along with establishing if fluid resuscitation practices have changed since SAFE-TRIPS, Fluid-TRIPS also aims to determine the relationship between fluid choice and evidence, along with understand other factors that may influence the choice of bolus fluid in clinical practice.

Interventions

None listed

Sponsors

The George Institute for Global Health, Australia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Adult patients present in the ICU on the study day or admitted during the 24-hour study period will be included in the study sample.

Exclusion criteria

Children under 16 years are excluded

Design outcomes

Primary

MeasureTime frameDescription
Type of resuscitation fluid in ICU24-hour study dayTo describe the amount and type of resuscitation fluid currently administered to adult patients in intensive care units (ICU) in different countries

Secondary

MeasureTime frameDescription
Cost comparison of fluid choice between regionsDesignated 24-hour study dayTo describe and compare the costs of fluid choice between different geographical regions

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026